# Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR Mutation

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/upregulation-of-pd-l1-by-egfr-activation-mediates-the-immune-escape-in-egfr/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Nan Chen,Wenfeng Fang,Jianhua Zhan,Shaodong Hong,Yanna Tang,Shiyang Kang,Yaxiong Zhang,Xiaobo He,Ting Zhou,Tao Qin,Yan Huang,Xianping Yi,Li Zhang |
| Citations | 689 |
| DOI | 10.1097/jto.0000000000000500 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.jto.org/article/S1556086415330422/pdf |
| OpenAlex ID | https://openalex.org/W2088270805 |
| PMID | 25658629 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Wenfeng Fang](https://scholariq.org/researchers/wenfeng-fang/)

## Paper journal

- [Journal of Thoracic Oncology](https://scholariq.org/journals/journal-of-thoracic-oncology/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.